Repligen Cp (RGEN)
$215.47 3.22 (1.52%)
19:54 EST RGEN Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 9.41B
PE Ratio 303.48
Volume (Avg. Vol.) 417,700
Day's Range 212.40 - 217.78
52-Week Range 78.41 - 221.38
Dividend & Yield N/A (N/A)
RGEN Stock Predictions, Articles, and Repligen Cp News
- From InvestorPlace
- From the Web
Repligen stock jumped 9% on the heels of the report to a new 52-week high of $203.90 today. And Louis Navellier sees a lot more upside for the company. Here's what potential RGEN stock investors should know.
The pandemic isn't the only reason you should be looking a pharmaceutical stocks. Here are six pharma companies that stand out with or without Covid-19.
Even a vaccine that's 50% effective with some side effects would be a game changer. The Trump Administration is throwing billions into that hope and investors are seeing big profits.
While many companies were unable to avoid the wrath of the coronavirus pandemic, these three companies stood out as big winners.
Much of the conversation about pharmaceutical stocks rests on the coronavirus, but these high-growth names have potential beyond the pandemic.
Smart beta ETFs typically rebalance every 90 days. The next big rebalance will come in the next few weeks and likely push healthcare stock Repligen (RGEN) higher.
When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).
By Ken Trester
This morning, I am recommending a bullish trade on Repligen Corporation (NASDAQ:RGEN), the bioprocessing company.
Investors are in for a wild ride later this week as Under Armour prepares to report its first-quarter earnings results before the open on Thursday.
The following stocks were moving the Manufacturing sector today.
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Healthcare stocks rose broadly on Wall Street on Thursday morning, with the sector seeing an overall increase of 0.3%.
Healthcare stocks rose broadly on Wall Street on Friday, with the sector seeing an overall increase of 0.6%.
These 7 top-rated biotech stocks are priced right, and are capable of weathering the market's recent downturn.
Healthcare stocks remained flat on Monday morning on Wall Street.
Navellier RatingsPowered by Portfolio Grader